Rocket Pharmaceuticals, Inc. (RCKT) has a consensus analyst rating of Buy, based on 19 analysts covering the stock. Of those, 13 recommend buying, 4 recommend holding, and 2 recommend selling.
The analyst consensus price target for RCKT is $5.00, representing a +28.9% upside from the current price of $3.88. Price targets range from a low of $5.00 to a high of $5.00.
